BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36361209)

  • 1. Computer-Assisted Annotation of Digital H&E/SOX10 Dual Stains Generates High-Performing Convolutional Neural Network for Calculating Tumor Burden in H&E-Stained Cutaneous Melanoma.
    Nielsen PS; Georgsen JB; Vinding MS; Østergaard LR; Steiniche T
    Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A machine learning algorithm for simulating immunohistochemistry: development of SOX10 virtual IHC and evaluation on primarily melanocytic neoplasms.
    Jackson CR; Sriharan A; Vaickus LJ
    Mod Pathol; 2020 Sep; 33(9):1638-1648. PubMed ID: 32238879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment.
    Szumera-Ciećkiewicz A; Bosisio F; Teterycz P; Antoranz A; Delogu F; Koljenović S; van de Wiel BA; Blokx W; van Kempen LC; Rutkowski P; Christopher van Akkooi A; Cook M; Massi D;
    Eur J Cancer; 2020 Sep; 137():175-182. PubMed ID: 32781392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologist-level classification of histopathological melanoma images with deep neural networks.
    Hekler A; Utikal JS; Enk AH; Berking C; Klode J; Schadendorf D; Jansen P; Franklin C; Holland-Letz T; Krahl D; von Kalle C; Fröhling S; Brinker TJ
    Eur J Cancer; 2019 Jul; 115():79-83. PubMed ID: 31129383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematoxylin and eosin or double stain for CD34/SOX10: Which is better for the detection of lymphovascular invasion in cutaneous melanoma?
    Ricci C; Dika E; Lambertini M; Ambrosi F; Grillini M; Chillotti S; Corradini AG; Veronesi G; Fiorentino M; Corti B
    Pathol Res Pract; 2022 May; 233():153876. PubMed ID: 35390633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts.
    Haggenmüller S; Maron RC; Hekler A; Utikal JS; Barata C; Barnhill RL; Beltraminelli H; Berking C; Betz-Stablein B; Blum A; Braun SA; Carr R; Combalia M; Fernandez-Figueras MT; Ferrara G; Fraitag S; French LE; Gellrich FF; Ghoreschi K; Goebeler M; Guitera P; Haenssle HA; Haferkamp S; Heinzerling L; Heppt MV; Hilke FJ; Hobelsberger S; Krahl D; Kutzner H; Lallas A; Liopyris K; Llamas-Velasco M; Malvehy J; Meier F; Müller CSL; Navarini AA; Navarrete-Dechent C; Perasole A; Poch G; Podlipnik S; Requena L; Rotemberg VM; Saggini A; Sangueza OP; Santonja C; Schadendorf D; Schilling B; Schlaak M; Schlager JG; Sergon M; Sondermann W; Soyer HP; Starz H; Stolz W; Vale E; Weyers W; Zink A; Krieghoff-Henning E; Kather JN; von Kalle C; Lipka DB; Fröhling S; Hauschild A; Kittler H; Brinker TJ
    Eur J Cancer; 2021 Oct; 156():202-216. PubMed ID: 34509059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX10: a useful marker for identifying metastatic melanoma in sentinel lymph nodes.
    Willis BC; Johnson G; Wang J; Cohen C
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):109-12. PubMed ID: 25356946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Sox10 and c-kit in sinonasal mucosal melanomas arising in the Chinese population.
    Liu HG; Kong MX; Yao Q; Wang SY; Shibata R; Yee H; Martiniuk F; Wang BY
    Head Neck Pathol; 2012 Dec; 6(4):401-8. PubMed ID: 22736149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX10/keratin dual-color immunohistochemistry: An effective first-line test for the workup of epithelioid malignant neoplasms in FNA and small biopsy specimens.
    Mito JK; Conner JR; Hornick JL; Cibas ES; Qian X
    Cancer Cytopathol; 2018 Mar; 126(3):179-189. PubMed ID: 29385322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of sentinel lymph node biopsy in patients with melanoma].
    Ren M; Kong YY; Cai X; Shen XX; Lyu JJ
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):360-365. PubMed ID: 29783803
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma.
    Gambichler T; Petig AL; Stockfleth E; Stücker M
    Clin Exp Dermatol; 2016 Oct; 41(7):709-16. PubMed ID: 27663144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX10 commonly stains scar in Mohs sections.
    Donaldson MR; Weber LA
    Dermatol Online J; 2020 Jan; 26(1):. PubMed ID: 32155034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX10 expression in superficial spreading and nodular malignant melanomas.
    Agnarsdóttir M; Sooman L; Bolander A; Strömberg S; Rexhepaj E; Bergqvist M; Ponten F; Gallagher W; Lennartsson J; Ekman S; Uhlen M; Hedstrand H
    Melanoma Res; 2010 Dec; 20(6):468-78. PubMed ID: 20890226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep contrastive learning based tissue clustering for annotation-free histopathology image analysis.
    Yan J; Chen H; Li X; Yao J
    Comput Med Imaging Graph; 2022 Apr; 97():102053. PubMed ID: 35306442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated quantification of proliferation with automated hot-spot selection in phosphohistone H3/MART1 dual-stained stage I/II melanoma.
    Nielsen PS; Riber-Hansen R; Schmidt H; Steiniche T
    Diagn Pathol; 2016 Apr; 11():35. PubMed ID: 27062658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of malignant melanoma in H&E-stained images using deep learning techniques.
    Alheejawi S; Berendt R; Jha N; Maity SP; Mandal M
    Tissue Cell; 2021 Dec; 73():101659. PubMed ID: 34634635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic performance of melanocytic markers for immunocytochemical evaluation of lymph-node melanoma metastases on cytological samples.
    Ronchi A; Zito Marino F; Toni G; Pagliuca F; Russo D; Signoriello G; Moscarella E; Brancaccio G; Argenziano G; Franco R; Cozzolino I
    J Clin Pathol; 2022 Jan; 75(1):45-49. PubMed ID: 33509946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas.
    Tacha D; Qi W; Ra S; Bremer R; Yu C; Chu J; Hoang L; Robbins B
    Arch Pathol Lab Med; 2015 Apr; 139(4):530-6. PubMed ID: 25436903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics.
    Palla B; Su A; Binder S; Dry S
    Am J Dermatopathol; 2013 Jul; 35(5):576-81. PubMed ID: 23291581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.